AI-Designed Dog Cancer Vaccine Startup Gamgee Raises $4M Seed
机器之心 · wechat · 2026-08-23
Paul Conyngham, a tech entrepreneur with no medical background, used AI tools like ChatGPT and AlphaFold to design a personalized mRNA vaccine for his dog Rosie, which initially reduced her tumors. Although Rosie eventually passed away, this effort led to the founding of Gamgee.
Gamgee has raised $4 million in seed funding led by Founders Fund. The company aims to industrialize this personalized workflow, sequencing tumors and using AI to identify neoantigens for custom "N-of-1" vaccines for dogs. Clinical trials are launching in Australia. The story highlights that while AI accelerates target identification, the bottleneck for personalized cancer vaccines remains the overall timeline of approval and production.
Related event: Founder Who Used AI to Design Cancer Vaccine for His Dog Raises $4M(2 posts)→
More from Venture
- Bears getting euphoric as big short seller John Hempton says he's enjoying the day — toptickcrypto · 2026-10-16
- AI-driven job losses could turn $10T consumer debt into a $1T banking hole — churchkey · 2026-10-16
- I/O Fund: the 17-year bull market has room to run, but a ~20% correction comes first — Beth_Kindig · 2026-10-16
- TSMC Q3 revenue hits $46.7B, up 41% YoY; Q4 guidance of $52-54B tops estimates — Beth_Kindig · 2026-10-16
- BytePlus-backed AI Film Award offers $1M grand prize for films 70% made with Seedance — DavidmComfort · 2026-10-16
- dunkhippo33 on startup timing: most great ideas only exist because they weren't possible before — dunkhippo33 · 2026-10-16